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Abstract 
 
 
 
 
Introduction: Normal lipid metabolism in the adipose tissue, skeletal muscle and aortic wall 
is important for the physiological function of these tissues. Dyslipidemia that is often 
associated with intake of high energy diet and sedentary lifestyles can lead to the development 
of insulin resistance and cardiovascular diseases. Existing methods for imaging the 
heterogeneous distribution of lipids in the skeletal muscle and adipose tissue is limited. Our 
aim is to, without probing and chemical fixation, identify and image the spatial distribution of 
lipids in the skeletal muscle, adipose tissue and aorta, and to reveal an altered lipid pattern in 
the skeletal muscle associated with obesity and in the aorta associated with high glucose 
intake. To achieve this, we used time-of-flight secondary-ion mass spectrometry (TOF-SIMS) 
equipped with a bismuth (Bi)-cluster gun which is a new technique for molecular imaging of 
biological samples. Principal component analysis (PCA) was used for studying changes 
between experimental and control groups. 
Methods: Human adipose and skeletal muscle tissue were obtained from obese youths and 
aortas were taken from Wistar Rats with or without glucose drinking. The samples were 
prepared by high pressure freezing, freeze-fracturing. Gastrocnemius skeletal muscle was 
taken from obese ob/ob mice and lean wild-type mice. The tissue was cryofixed and 
cryosectionized. All samples were dehydrated by a freeze drying process in ultra high 
vaacum. The tissue was analyzed by TOF-SIMS. Semi-quantitative measurements in the rat 
aorta and in the mice skeletal muscle were based on principal component analysis. 
Results: In the negative spectra, we identified fatty acids and triacylglycerol. In the positive 
spectra, we identified the phosphocholine, cholesterol and diacylglycerol. Heterogeneous 
distribution of these molecules was observed in the skeletal muscle and adipose tissue. By 
using PCA, we identified a reduced signal of cholesterol in rats with high glucose intake 
compared to control rats. The obese ob/ob mice showed an increased level of fatty acids and 
diacylglycerol. The ratio between fatty acid peaks showed changed fatty acid composition in 
the rat aorta associated with high glucose intake and in the mice skeletal muscle associated 
with obesity. 
Conclusions: With the help of imaging TOF-SIMS, it is possible to depict the heterogeneous 
localization of fatty acids, phosphocholine, cholesterol, diacylglycerol and triacylglycerol in 
the adipose tissue, skeletal muscle and aortic wall. Moreover, imaging TOF-SIMS together 
with PCA analysis of TOF-SIMS spectra is a promising tool for studying lipid alterations in 
tissues. 
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INTRODUCTION 
Obesity induced by sedentary lifestyle and energy-rich diet is an increasing problem around 
the world. Millions of people are suffering from overweight, a problem which is hazardous to 
their health and leading to premature death. Obese animals and humans accumulate lipids not 
only in the adipose tissue, but also in other tissues such as the liver, skeletal muscle and the 
aortic wall. This so-called non-ectopic lipid accumulation is a strong contributor to the 
development of insulin resistance, type-2 diabetes and cardiovascular disease [1-4]. On the 
basis thereof, it is necessary to further investigate the lipid distribution pattern in those tissues. 
Time-of-flight secondary ion mass spectrometry (TOF-SIMS) with the use of Bismuth 
clustering ions is an imaging mass spectrometry method with high lateral resolution, which 
permits identification and localization of lipids without probing and chemical fixation. This 
method provides information about the chemistry of tissue samples, and represents a new 
approach for identifying and imaging lipids in biological tissues.  
 
Dyslipidemia and Insulin resistance 
Insulin, a protein hormone produced by pancreatic β-cells is needed for the control of both 
carbohydrate and lipid metabolism [5]. Consequently, failure in insulin signalling has 
widespread and devastating effects on many organs. When the amount of insulin is 
insufficient to produce a physiologically adequate insulin response from fat, muscle and liver 
cells, insulin resistance develops [6,7]. As a result, the possibility to store lipids within the 
adipose tissue fails. The free fatty acid (FFA) uptake by the adipose tissue is decreased and 
the stored triacylglycerol (TAG) is hydrolyzed. This causes an augmented FFA release by the 
adipocytes, resulting in elevated plasma FFA [8,9]. When excess FFA is transported to the 
skeletal muscle, this will lead to lipid overloading in muscle cells which will prevent glucose 
uptake and utilization [10,11]. More specifically, accumulation of intermediates of lipid 
metabolism, such as diacylglycerol (DAG) and Acyl-CoA has been shown to interfere with 
insulin signalling [12]. In the liver, high FFA level decreases its ability to store carbohydrates, 
which consequently leads to elevated blood glucose. High plasma insulin levels of and 
glucose due to insulin resistance often lead to metabolic syndrome with an increased risk of  
both atherosclerosis and type-2 diabetes[13-15] .  
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Lipids 
The primary function of lipids in biological systems is to store energy, predominately in the 
form of TAG. Lipids are also the important integral components in the cell membrane, and 
they can act as secondary messengers in signal transduction or produce prostaglandins. 
Further, other purposes of lipids are to function as vitamins and hormones. Choline is an 
amine originated in the lipids. Choline is vital for the build up signalling functions of cell 
membranes, and in the formation of phosphocholine as reviewed by Vance et Vance [16]. 
Abnormal lipid metabolism is strong contributors to insulin resistance, type-2 diabetes and 
cardiovascular diseases. For example, in obesity many studies show that both saturated fatty 
acid (SFA), and monounsaturated fatty acids (MUFA) are upregulated, and that 
polyunsaturated fatty acid (PUFA) are decreased [17]. 
  
  
                  
Figure 1 a) Cellular membrane                                         b) Lipid raft component  
Phospholipids 
The glycerol-based phospholipids (e.g. glycerophospholipids) constitute one of the most 
abundant structural components of biological membranes. Together with cholesterol and 
glycolipids (e.g.sphingolipids) they create an essential milieu of cellular membranes (Fig.1a) 
[18,19]. The saturation degree of fatty acid  residues of phospholipids determines the 
membrane fluidity which in turn directly affects most cellular processes Several double bonds 
provide the fatty acid chain with an unregular form which is affecting the melting point 
[16,20]. This has a major impact in different disease states including diabetes, obesity, and 
heart diseases [21]. SFAs, such as stearic acid (C18:0), are likely to contribute to the rigidity 
of membranes, since they can be packed tightly in the phospholipid membrane [22]. Both 
sphingomyelins and phosphatidylcholine contain phosphocholine as the polar head group, but 
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their hydrophobic backbone is different. Sphingomyelin synthesis involves the transfer of 
phosphocholine from phosphatidylcholine onto ceramide, producing DAG as a by-product 
[23].  
DAG 
DAG is a glyceride with two fatty acids esterfied with a glycerol molecule produced from 
glycerol-3-phosphate pathway [24,25] or synthesised from acylation of monoacylglycerol 
[26]. DAG can be further converted to phosphatidylcholine and phosphatidyletanolamine or 
TAG [16]. DAG is not a major component of biological membranes, but plays a significant 
role in both intermediate metabolism and in signal transduction as a second messenger and 
has been shown to accumulate in the insulin-resistant muscle of high-fat fed rats [27,28].  
Increased levels of DAG may be due to chronic hyperinsulinemia or by hydrolysis of 
phosphatidylcholine.  
Cholesterol 
Cholesterol is another lipid that plays a major role in the membrane structure. However, 
excessive cholesterol is involved in the formation of atherosclerotic lesions [16]. Cholesterol 
is transported in the plasma predominantly as cholesteryl esters associated with lipoproteins 
[29]. Acetyl-CoA derived from fatty acids or pyruvate in mitochondria β-oxidation is utilized 
in cholesterol biosynthesis. A dynamic clustering of sphingolipids and cholesterol forms rafts 
in the lipid bilayer (see figure 1b) [30]. Lipid raft appears to be a mechanism to group various 
processes on the cell surface by bringing together various receptor mediated signal 
transduction processes [31].  
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Figure 2    Illustration over chain elongation and desaturation of fatty acids 
Chain elongation and desaturation of fatty acids 
Fatty acids are a major source of energy in β-oxidation in animals. Fatty acids are also the 
intermediate in the synthesis of phospholipids and eicosanoid, DAG and TAG. TAG is built 
up by a glycerol backbone and three esterfied fatty acids. The fatty acid composition of TAG 
reflects the diet. In animals, the composition tends to be simple, with C16 (mainly 16:0) and 
C18 (mainly C18:1) fatty acids predominating. If one of the fatty acids in TAG is replaced by 
a phosphate group, a phospholipid is obtained. There are three major groups of fatty acids; 
saturated fatty acid (SFA), mono unsaturated fatty acid (MUFA) and polyunsaturated fatty 
acid (PUFA). New synthesis of fatty acids starts with palmitic acid (C16:0) and some stearic 
acid (C18:0). C16 and C18 fatty acids are the major components of many membrane lipids. 
However, long-chain fatty acids are also seen. In myelin for example, over 60% of fatty acids 
are 18 carbons or longer, and in sphingolipids 24 carbon acyl chains are well-known. Chain 
lengths of 28-36 carbon have been reported in the phospholipids of the retina photoreceptors 
[32]. Elongation of fatty acids from palmitic acid (C16:0) requires an elongation enzyme [33]. 
In eukaryotes, the production of very-long-chain SFA, PUFA (C20 – C26) takes place 
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independently of fatty acid synthetase (FAS) by membrane-bound elongases on the cytosolic 
face of the endoplasmic reticulum (ER) membrane [34]. Fatty acid desaturase introduces 
double bound specific locations in the acyl-chain. By successive actions of elongase and 
desaturase enzymes the fatty acid chains decide the physiological properties of the membrane 
function. There are three different desaturase occurring in mammals: delta 9 desaturase, delta 
6 desaturase and delta 5 desaturase. The delta 9 desaturase, is also known as stearoyl-CoA 
desaturase -1 (SCD-1) and is used to synthesize palmitoleic (C16:1) and oleic acid (C18:1) by 
insertion of a cis-double bond in the delta 9 position of the fatty acid chain. The delta 6 and 
delta 5 desaturase are required for the synthesis of PUFA such as arachidonic acid, 
eicosapentanoic acid (EPA) and docosahexaenoic acid (DHA), where alpha-linolenic acid 
(ALA; 18:3n–3) are the precursor for EPA and DHA. While, arachidonic acid is synthesized 
from linoleic acid (LA; 18:2 n-6) and is the precursor for prostaglandins [35-37]. All the 
essential fatty acids, such as linolenic and -linolenic acid, must come from the diet, since 
mammals are incapable of producing these fatty acids by themselves. 
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Figure 3 Illustration of the adipose tissue 
 
The Adipose tissue 
The characteristics 
Adipose tissue is a loose connective tissue composed of adipocytes in an abundant capillary 
bed; this was known as early as 1850 in work by Fleming [38]. In the middle of 1900 Mirski 
and co-workers found the adipose tissue to be an active organ with a specific carbohydrate 
metabolism [39], and at the same time Reynolds and Marble found the lipolytic activity of the 
adipose tissue in rat and man [40]. Histochemical techniques and chemical analysis showed 
that insulin increased glycogen synthesis in this tissue [41]. Del Vecchio et al showed the 
distribution and concentrations of cholesterol in skeletal muscle and adipose tissue [42]. 
Adipose tissue involvement in insulin resistance and obesity was recognized by Rabinowitz in 
1960 [43]. However, since the introduction of the gas-liquid chromatography technique the 
same decade, more detailed information has been obtained. Hirsch, Hegsted and co-workers 
showed the fatty acid composition of the adipose tissue in different region of the body [44]. 
Siiteri et al identified the adipose tissue as a major site for metabolism of sex steroids (i.e. 
estrogens and cortisone/cortisol) [45]. In the middle of the 1990’s, the hormone leptin was 
identified to be produced by the adipocytes. Hence, the adipose tissue was considered as an 
endocrine organ [46]. Today, the adipose tissue is established as a complex and highly active 
metabolic and endocrine organ, which is releasing a number of hormones such as tumor 
necrosis factor-alpha (TNF-α), Interleukin-6 (IL-6) and adiponectin [47-49] . 
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The lipid metabolism 
The lipid droplet is endured by a core of lipids, which mostly consists of TAG (90-99%) and 
to a lesser amount of DAG, FFA, phospholipids and monoacylglycerol. The oleic acid (47%) 
and palmitic acid (19%) are the dominate fatty acids [50]. However, variation in the dietery 
fatty acid composition can change the fatty acid profile in the adipose tissue. The 
concentration of DAG in the adipocyte is 1% of the total lipid amount. In addition to their 
TAG storage, the adipocytes are a deposit for unesterified cholesterol [51,52]. There is 
approximately 1-5 mg cholesterol per 1g of TAG [53]. The unesterified cholesterol is mainly 
situated in the cholesterol-rich ER-like surface structures in the cell membrane [54-56]. This 
might function as a membrane pool to maintaining a stiff cellular membrane because the cell 
is expanding rapidly [51]. When the adipocyte is enlarging due to increased TAG loading the 
cholesterol follows, a smaller portion are found as cholesteryl esters in the lipid droplets, 
surrounded by an amphipathic monolayer of phospholipids [57]. The adipocytes are able to 
synthesize cholesterol from acetate and mevalonate, which has been shown in rats [58]. There 
are also specific proteins in the adipose tissue; perilipins and adipose differentiation- related 
protein (ADRP) to mention some of them [59], and a nucleus pressed in the periphery. The 
lipid droplets form rapidly in response to elevated fatty acid levels [60]. It has been shown 
that lipid droplets form from discrete regions of the ER [61] and expand independent of the 
TAG accumulation, after assembled due to a fusion process which requires intact 
microtubules [62]. Intake of carbohydrate diet leads to glycogen synthesis by the liver. 
However, only a few grams of glucogen can be stored before lipogenesis starts. TAG made by 
the lipogenesis is transported from the liver by apolipoprotein (VLDL or chylomicrons) in the 
blood plasma [63]. TAGs are hydrolyzed by lipases (LPL) to fatty acids [64], and fatty acid 
are transported into the adipocyte. Once in the cell, fatty acids esterify onto glycerides at rates 
dependent upon chain length and degree of unsaturation, and stored as TAG. Glycerol is the 
building block for TAGs in tissues other than adipose tissue but oxidation of glucose is 
necessarily performed in the adipocytes as they lack the enzyme glycerol kinase and use 
dihydroxyacetone phosphate as the precursor for TAG synthesis [65]. The main function of 
the adipose tissue is to provide a long-term energy reserve of, fatty acids that can be release 
for oxidation in other organs during food deprivation. Fatty acids are released from TAG by a 
hormone-sensitive lipase which is activated by phosphorylation dependent on protein kinase 
A (PKA) [66]. 
 
  15
 
 
Figure 4 Illustration of the skeletal muscle 
The skeletal muscle 
The structure 
The skeletal muscle consists of two main muscle fibre types, the red oxidative slow-twisted 
type I and the white fast-twisted fibres type II (a, and b) according to their amount of 
myoglobin and their mechanism to produce ATP [55,67]. In general, the type I muscle fibre 
has a greater oxidative metabolism, a greater lipid content and are more insulin-sensitive than 
the type II muscle fibre [13,68].  
Lipid metabolism  
The skeletal muscle uses FFA and glucose as substrate. Fat utilization by muscle was first 
shown in 1952 by Wertheimer et al [69]. The skeletal muscle is a major site of insulin action 
and relations between the fatty acid composition of phospholipids in skeletal muscle and 
insulin sensitivity have been reported [70]. In 1963, Randle and his group were the first ones 
to describe the relation between FFA in plasma and insulin resistance in skeletal muscle [71]. 
In 1967 Denton and Randle described lipid storage of in the rat gastrocnemius muscle [72]. 
The TAG content in skeletal muscle is increased in obesity [73,74]. The amount of the 
intramyocellular lipid in obese individuals is approximately 3–4% of total fibre area, whereas 
in the muscle of lean persons, this value decreases to 1–2 %. The dominating fatty acids in the 
skeletal muscle are palmitic and oleic acids, closely followed by linolenic acid [75]. Muscle 
TAG content has been shown to be positively correlated with serum TAG in diabetes subjects 
[76]. The skeletal muscle consist of approximately 0.25nmol DAG per mg tissue. DAG in 
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skeletal muscle has been shown to be upregulated in insulin resistance and type 2 –diabetes 
[12]. There is also a minor amount of cholesterol in the skeletal muscle [42]. 
 
 
 
Figure 5 Illustration of the arortic divided in three different layer.  
Tunica intima, tunica media and tunica adventita 
 
The aortic wall 
The structure 
The aortic wall is divided into three layers, tunica intima, tunica media, and tunica adventitia.  
Tunica intima consists of a single layer of endothelial cells and some loose connective tissue, 
proteoglycans and the elastic lamina which separates the intima and the tunica media. The 
media consists of smooth muscle cells surrounded by elastic lamellae (e.g. collagen and 
elastine) and the tunica adventitia is composed of loose connective tissue layer with 
fibroblasts, collagen fibres, small blood vessels and nerves, and is the link between the artery 
and the surrounding tissue [77].  
The lipid metabolism 
The arterial wall is known to be metabolically active tissue with the capacity for lipid 
synthesis and possesses all necessary enzymes for this process. The supply of nutrients to the 
aortic wall goes via the luminal side [78]. Glucose is known to be the major substrate for the 
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arterial wall and endothelial cells have been shown to utilize exogenous glucose at 
physiological concentrations for their energy production [79]. Aortic endothelial cells do 
express insulin receptors with characteristics similar to those in other tissues, and GLUT1 is 
the major glucose-transporting protein in endothelial cells [80]. Further, the vascular smooth 
muscle cell utilizes primarily medium-chain fatty acids as substrate for energy [78]. TAG is 
synthesised from fatty acids and glucose is active in the arterial wall in response to insulin. 
They also express lipases that hydrolyse TAG in response to low insulin levels [81]. Elastic 
tissue has been shown to be important for the lipid accumulation in the aortic wall where it 
forms stable complex together with lipids [82]. Atherosclerosis is a cardiovascular disease 
related to intake of high fat diet and accumulation of lipids in the intima and media of the 
aortic wall.  
Cholesterol 
Different species response differently to cholesterol feeding, rat for example has been shown 
to have only a minor elevation of serum cholesterol levels, whereas in humans the plasma 
cholesterol level is increased moderate when fed with cholesterol-rich diet [83]. Plasma 
cholesterol is an important source of cholesterol in the aortic wall where it is transported with 
lipoprotein VLDL and LDL particles. The subendothelial retention of lipoproteins in the aortic 
wall is a key initiating process in atherogenesis [84]. The synthesies of cholesterol in the 
aortic wall has been demonstrated in several animals and humans [16,85]. Cholesterol 
homeostasis in the body is dependent on several factors, such as absorption, synthesis, 
storage, and excretion. The cholesterol concentration in humans and animals is at a constant 
level [86]. Cholesterol can be hydrolysed and excreted from the arterial wall [87] and is 
transported back to the liver by HDL-cholesterol proteins. The efflux of cholesterol from 
tissues goes via liver X receptors (LXR) situated in both macrophages, endothelial cells and 
smooth muscle cells [88,89]. LXRs operate as cholesterol sensors which protect from 
cholesterol overload [90]. 
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Need of new methodology 
Interests in studying lipid and metabolic disorders are expanding quickly. To cope with all 
these advances in disease research an imaging technique is. This has motivated to explore 
TOF-SIMS imaging techniques for further studies in lipid research, to discover lipids within 
biological tissues. Different methods have been used in the past. Electromicroscopy provides 
information about lipids in relation to organelles [91]. Histochemical staining with Oil Red O 
or Sudan dye is used to nonspecifically localize neutral lipids, while lipid-specific 
fluorescence probes are only available for cholesterol [92,93]. Chromatography methods 
previously used for lipid identification include gas chromatography, thin layer 
chromatography and high-performance liquid chromatography (HPLC). The separation of 
gangliosides for example was done by the use thin-layer chromatography and mass 
spectrometry [94,95]. HPLC separates TAG, DAG, acetates and even intact phospholipids by 
degree of unsaturation [96]. However, these techniques require extraction steps and lipid 
derivatization from tissues, which are both time-consuming and requires relatively large 
amounts of tissues and may result in lipid mobilization. Moreover, these techniques cannot 
reveal the heterogeneous distribution of lipids in the biological tissues. Different mass 
spectrometry (MS) techniques have been used in lipid research. For example, multiple 
precursor ions scanning hybrid quadrupole time of flight has been used very successfully in 
quantitative profiling of phospholipids [97]. Matrix enhanced SIMS (ME-SIMS) has been 
used for imaging phosphatidylcholine and sphingomyelin at cellular level [98]  and Matrix-
assisted laser desorption/ionization mass spectrometry (MALDI-MS) has been used for mass 
determination and distribution of phosphatidylcholine and cerebroside in rat brain [99]. 
MALDI-MS coupled with a time-of-flight technique leads to the acquisition of images with 
high mass resolution but relatively low spatial resolution, and the signal visibility is low, 
because of mass interference with matrix ion peaks [100]. Raman mapping and Fourier 
transform infrared (FTIR) imaging spectroscopy have been used for identifying 
polymorphism of ceramide [101]. However, these methods are lacking from chemical 
specificity. 
 
 
  19
Time of Flight Secondary Ion Spectrometry 
TOF-SIMS ion microscope affords molecule-specific information without the incorporation 
of dye, isotopes or labels. Static TOF-SIMS is a surface-sensitive method where the primary 
ion dose is low, and thus provides molecular information of the sample surface with minor 
damage.The use of TOF-SIMS permits ion imaging in areas as large as 500 µm2. Allow 
visualization of the morphology, topology, and chemical composition of significant peaks in 
the spectrum from the biologic samples with molecular weight of some thousand daltons. A 
recent modification is to use bismuth (Bi3+) cluster ion as the primary ion source, which 
increased spatial (100 nm) and mass (m/∆m 5000-10000) resolution [102] makes it possible, 
without any chemical pretreatment of the tissue, to measure directly the intensity of, and map, 
biomolecules within the tissues [103,104]. TOF-SIMS has several advantages. It has the 
possibility to direct compare signal intensity of different molecules in biological tissue and the 
ability to analyze sequential layers to form a three-dimensional analysis. Moreover, its 
detection of atomic concentrations can be as low as 10 ppm.  
Historic 
Secondary ion mass spectrometry (SIMS) is a relatively new technique for investigation in 
biological research. The first prototype to SIMS was developed by Castaing and Slodzian in 
the early 1960 in parallel to the Americans Liebel and Herzog [105]. There are two different 
operational regimes in SIMS, the dynamic and the static, which provides fundamentally 
different information. Dynamic SIMS, with a single non-pulsed primary beam is a rather 
destructive technique. The high numbers of bombarding ions allows depth profiling, reaching 
several microns with elemental sensitivity. The maximum mass range is typically ~ 250 m/z. 
The static SIMS appeared when Benninghoven (1970) reduced the primary ion current density 
on the sample [106]. It was first used to analyze inorganic compounds as oxids layers on 
metals, or mapping organic contaminats on semiconductors devices [107,108]. Static SIMS is 
surface mass spectrometric techniques which gives information about the chemical 
composition of the upper most monolayer of the bombarded surface with a high mass 
resolution. The technique creates some destruction of tissues and therefore it is necessary to 
use a very low dose of primary ions. Less than 1% of the top surface layer of atoms or 
molecules receives an ion impact [109]. Vickerman and his team saw the possibilities of static 
SIMS to be developed into a surface mass spectrometry in the middle of the 1970 [110], and 
from this technique, the TOF-SIMS instrument was developed. The first results were reported 
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by Chait and Standing in 1981 [111]  by the implementation of TOF analyzers which 
achieved a significant improvement in mass resolution and transmission efficiency imaging 
[112-115]. Many interesting works have been done since the beginning of the 1980. For 
example 1981, Burns detected ions in the cat choroidea and in 1982, Na+ and In+ were 
detected in the kidney and cardiac tissue from rat [116]. The most famous one is the mapping 
of stable and radioactive isotopes in the thyroid gland by Berry et al in 1986 [117]. TOF-
SIMS has also been used for drug detection in cells (anti-tumor drugs in histological sections) 
[118] to better evaluate successful early cancer treatments. Drug detection is accomplished 
indirectly by detecting a tag isotope naturally present or introduced by labeling, mainly with 
halogens,15N and 14C [118-120]. 
 
Imaging and detection of lipids with TOF-SIMS 
Detection of lipids with TOF-SIMS was introduced by McMahon in 1995 by the imaging and 
detection of phosphatidylcholine and sphingomyeline in porcine brain and dog adrenal gland 
[121]. The same year Seedorf manages to detect cholesterol in blood from patients suffering 
from Smith-Lemli-Opitz syndrome [122], which is another example of early TOF-SIMS 
studies in the biomedical field. The technique is still developing mainly due to the 
development of new primary clustering sources as buckminister fulleren (C60+), gold (Au+) 
and bismuth (Bi+). Its use in biological research is expanding. McQuaw et al have identified 
sphingomyelin in cholesterol domains in the process of raft formation in cellular membranes 
[123]. They have detected lateral heterogeneity of dipalmitoyl phosphatidylethanolamine-
cholesterol in Langmuir-Blodgett film [124]. Using Au3+ cluster ions Sjövall et al 
demonstrated cholesterol, sulfatides, phosphatidylinositols, and phosphatidylcholine [125]. 
Later on the Bi3+ cluster ions have been used in the localization of cholesterol, 
phosphocholine and galactosylceramide in rat cerebellar cortex [126,127]. 
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Figure 7 Schematic drawing of TOF-SIMS instrument 
 
Principal of TOF-SIMS in biological samples 
The “Time-of-Flight” of an ion is proportional to the square root of its mass, so that all 
different masses are separated during the flight and can be detected individually [128]. The 
sample is sputtered by a primary ion beam with energy between 5 and 25 keV. The beam can 
be pulsed with a puls lengt from ns up to µs. This generates a sort of collision cascade of 
atoms and molecules of the <3 upper most layer of the sample surface [129]. A cloud of atoms 
and molecules arises; most of them are neutrals only, some (approx. 1%) are ionized as 
secondary ions, positively or negatively charged [130]. The emitted ionized particles with 
different masses leave the surface at the same time via the deflection of the electron 
trajectories due to the Lorentz force which is transmitted into kinetic energy. Ions are 
separated charged by the TOF extraction optics. Ions are accelerated to a given energy with an 
electric potential and transferred into a field-free flight path of vacuum of approximately 2m. 
With a certain amount of kinetic and internal energy “they” are travelling in free and are 
separated by their mass in the end of the flight path the ionized particle hits a “detector” 
where the ions are detected and counted. The flight times of all the ions to the detector are 
electronically measured and related to the ion mass (m/z) [113,131]. Moreover, some of the 
identical secondary ions will leave the sample surface with different kinetic energy, which 
results in a decreased resolution due to a band broadening. To compensate for this, the 
instrument is equipped with a type of “mirror” called the reflectron in the end of the flight 
path. Ions with same mass-to-charge ratio but higher kinetic energy penetrate deeper into the 
reflector, delaying their time of arrival to the detector than the slower low-energy ions. This 
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process increases the resolution of the mass spectra [132]. Hence, for each primary ion pulse, 
a full mass spectrum is obtained. Thus a mass spectrum of all the ions is generated from the 
flight time spectrum. Every mass spectrum is transformed to one pixel in the image. One 256 
x 256 pixel image contains 65.536 distinct mass spectra; each of them contains several 
hundreds of ion peaks.   
 
 
 
Figure 6 Illustration of the sputtering process with emissions of secondary ion   
 
Primary ion source  
The secondary ion yield depends to a large extend of the primary ion source. The basic types 
of ion guns for SIMS are the electron impact gas ion guns, surface ionization and liquid metal 
ion gun (LMIG). The electron impact gas ion gun operates with noble gases as argon (Ar+), 
Xenon (Xe+), oxygen (O-, O2+), SF5+ ionized molecules and C60+. These primary ion sources 
have been used mostly in dynamic SIMS that gives information about in-depth composition of 
the sample. Oxygen for example has been used in detection of positive ions such as 
magnesium (Mg+) isotopes in the kidney [133]. The surface ionization source use Cesium 
(Cs+) as the primary beam. Cs+ produces a higher beam current and enhances the secondary 
ion yield, and it is mostly used for generating negative secondary ions [134,135] and as been 
used to localize isotopes in melanoma cells and tumour-infiltrating macrophages [136]. The 
LMIG uses liquid metals (at room temperature) as gallium (Ga+), indium (In+), Au+, and Bi+ 
as primary ion source. LMIG supplies a well focused ion beam. Ga+ for example, offers high 
brightness and reasonable energy spread and has a lateral resolution of about 1 um. However, 
images obtained from tissue samples are generally limited to ions like the phosphatidylcholine 
headgroup of the membrane lipids at m/z 184 [126]. The major weakness of using 
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monoatomic primary ion sources, such as Ga+, has been the low ion intensities and the high 
fragmentation of the high mass secondary ions.  
A breakthrough with SIMS analysis resulted from the development of polyatomic cluster 
primary ion beam systems. Polyatomic ions involve the simultaneously collision of a number 
of atoms within a space of a few tenths of a nanometer. Because a cluster ion dissociates upon 
collision with a surface, the penetration depth of the elements of the cluster is reduced as 
compared to monoatomic primary ion bombardment [137,138]. This significantly increases 
the secondary ion yield and molecular specificity in the MS, even though the formation of 
oxide fragments arises with polyatomic ions [139]. The Au3+ cluster ion beams for example 
have the potential to increase the secondary ion yield to 3 orders of magnitude compared to 
the conventional monoatomic Ga+ [114]. By using Au3+ Touboul detected cholesterol at m/z 
385 in mouse brain [140] and later on different fatty acids and TAG in mouse leg [141]. The 
Bi3+ cluster ions give better intensities and efficiencies of ions and produces less 
fragmentation of the parent ions and allow a better lateral  and mass 
resolution[102,137,140,141]. The C60+ is another used cluster ion source [142]. The C60+ 
projectiles produce about a tenfold increase in the measured signal compared with Ga+. 
However, this thin primary ion source is primarily used for depth-profiling generating 3-
dimentional images [143].  
Sputtering process for organic ion is not fully understood. The ion impact on the target is of 
major importance. During high energetic bombardment when the sample is receiving a high 
amount of energy, a crater can form. This often occurs when heavy ion such as Cu+ or Au+ 
cluster are used. When crater is formed only half of the sputtered atoms leave the surface, the 
other half is stocked in form of a crater rim [134]. Moreover, ionization of secondary ions can 
be formed either as ionization of the entire molecule M, through an ejection of an electron as 
radicals (M+, M-), by protonation [M+H] +, de-proteonation [M-H]-, or cationisation by Na+, 
K+ or Ag+. The protonation (and de-protonation) or cationisation strongly depends on the 
matrix and this is referred as the matrix effect [144]. In principal the emission of secondary 
ions could be non-ionized in the absence of cations. On the contrary, adding Na+ or K+ salts to 
the sample the ionization of the analytes will occur. This was also shown in the presence of 
hydrogen-rich substrate [145]. To enhance the secondary ion yield other techniques can be 
used. For example, covering the sample by a nm-thick layer of gold or silver, has been shown 
to provide increased intensities for large analytes in biological tissue, so-called sample 
metallization (Meta-SIMS) [146]. 
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Quantitative SIMS 
Static SIMS produces qualitative information, but quantitative information is more 
complicated to obtain. However, even though TOF-SIMS is not being regarded as a 
quantitative technique, different quantitative approaches have been tried out with both static 
and dynamic TOF-SIMS. There are several factors that can influence the ion intensity in the 
sample, such as the chemical composition of the sample matrix, topography, matrix-and 
primary ion interactions, instrumental transmission, and detector response [114].  
One approache to acheiving quantitative SIMS data was the implantation of an ion (e.g. 
isotope) of known concentration into the sample of interest [147,148]. By this approach the 
difficulty to control chemical environment can be compensated by simultaneously depositing 
an internal standard with the similar properties. The sample is then sputtered and depth 
profiled and the reference material signals are integrated over the sputtered time. The 
integrated ion intensity of the reference material can then be directly related to its known 
concentration, and a relative concentration of other elements can be calculated. This has been 
used in work by Harris et al [149] for quantifying the calcium distribution in biological 
samples. Moreover, this was also used for quantitative analysis of the immunosuppressive 
drug cyclosporine A (CsA), in whole blood of organ transplant patients. In this study, 
cyclosporine D, an analog of CsA which does not exhibit immunosuppressive activity, was 
used as an internal standard. Good correlation was obtained between HPLC, which is the 
specific method for the CSA analysis, and TOF-SIMS and MALDI results [150]. Another 
used approached is to add deuterium labeled molecules as internal standard. For example, 
direct quantification of cocaine in urine has been achieved by use of deuterated cocaine as an 
internal standard [151]. Analysis of L-DOPA is another example were a linear calibration 
curves were constructed by integrating the protonated molecular ion to silver ion peak area 
ratios over a known ion dosage and plotting versus the original sample concentration [152]. In 
addition, semi-quantitative information may be obtained by ToF-SIMS by normalizing the 
intensity of a signal of interest to a ubiquitous ion that produces a reasonably stable signal 
across samples of interest. This ion serves as an internal standard to account for variations in 
ionization efficiency across a sample caused by, for example, topographical and matrix effects 
[153]. This was applied in the work by Ostrowski where they relatively quantified cholesterol 
in membranes of individual cells from differt subjects [154]. These authors used a fatty acid 
fragment C5H9+ as an internal standard to normalize the signal of interest. Relative 
quantitative approach is possible for tissue by using carbon (12C) as an internal reference. This 
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approach was used for the quantification of halogens and calcium [155]. Standard preparation 
was determined based on molecular incorporation (halogens) or mixing (calcium) in 
methacrylate resin. Standard measurements were performed by depth analysis. Results 
obtained show that the relationship between the signal intensity measured and the elemental 
concentration is linear in the range of biological concentrations [155]. SIMS quantification 
has also been used to measure the concentration of 14C –labeled molecules and their 
variabilities in different cells of human fibroblast. This procedure was assessed through local 
isotope 14C/12C ratio measurement. This relates the signal intensity of the labeled 14C to that of 
the corresponding natural isotope (12C) of known tissue concentration. Thus, differences in the 
concentration of arginine between different fibroblasts [156] could be obtained successfully.  
 
Tissue preservation method 
When preparing samples for TOF-SIMS analysis, several issues have to be taken into 
consideration. Preparation and fixation technique is very important to preserve the chemical 
and structural integrity of the tissue cells. Molecular species such as K+, Ca+, Na+ as well as 
some proteins can diffuse, thus leading to incorrect results [113]. It is also necessary to avoid 
contaminations as they could hide native molecules in the sample surface. Most cells and 
tissue contain more than 70 % water. Given that samples are analyzed in ultra high vacuum, if 
they are placed in vacuum directly, artifacts will be created. Consequently, water must be 
removed from the sample. Before samples are analyzed by TOF-SIMS the ice must be 
eliminated by freeze-drying. In the freeze-drying process the pressure is lowered and vacuum 
created, adding heat to this low pressure environment allows the ice to sublimate into vapor. 
The removal of ice during the freeze-drying process can cause biomolecules to undergo 
significant structure changes. However, time, pressure and temperature in the freeze-drying 
process are factors that can be adjusted to avoid unnecessary mobilization of ions. 
 
Cryo-sectioning can be immediately performed from liquid nitrogen (LN2) snap-frozen 
samples. The cryo-sectioned sample can than be mounted directly on electrically conducted 
substrates and freeze-dried prior to SIMS analysis. The rapidity of the cooling process is 
another important issue. High speed freezing is vital to limit the ice-crystal size and related 
damage of the cells [119]. Another way is to use liquid propane for rapid freezing, which 
protects samples from ice-crystals without any prefixation or cryoprotectants, however this is 
very hazardous [157]. The newest method in freezing without cryo-protectants is the high-
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pressure-freezing. High-pressure-freezing will immobilize all cells and/or tissue components 
immediately. This method is vitrifying the tissue fluids, i.e., absence of ice crystals, a so-
called amorphos-ice. This technique reduces osmotic effects [158] and shifting and loss of 
ions in the sample [159] that occur with chemical fixation. High-pressure-freezing is at 
present the only way to vitrify or freeze well biological samples thicker than 50 µm [160]. 
Other methods have been tried out, for example the gluteraldyd fixation in protein film [161]. 
This has been shown to be successful in protein analysis. 
Principal Component Analysis (PCA) 
PCA is a common statistical technique for finding patterns in data of high dimension and 
expressing the data in such a way as to highlight their similarities and differences by 
transforming a number of (possibly) correlated variables into a (smaller) number of 
uncorrelated variables called principal components (PC). So, the first principal component 
accounts for as much of the variability in the data as possible, and each succeed component 
expresses for as much of the remaining variability as possible [162-164].   
Data pre-processing 
The pre-processing of the data before PCA analysis is important so it transforms the data into 
a format that will be more easily and effectively processed for the purpose of the user. There 
are a number of different tools and methods used for preprocessing; the most common ways 
are auto-scaling, mean-centering and normalization.  
Auto scaling 
Auto-scaling of the spectra are used to get a fair comparison between variables with an 
unequal spread. By auto scaling all variables, i.e. by dividing each peak values with the 
standard deviation of that peak are scaled so unit variance achieves. Auto-scaling allows all 
variables to influence equally.  
Mean centering 
If the variables have the same units, mean-centering may be the suitable option because that 
variables (peaks) with significantly variation are in fact more important, i.e. include more 
information regarding the spectra in the study, compared to those peaks with small variation.  
Mean centering consists of subtracting each peak with respectively peaks mean to achieve 
clarity in the model. The mean of the peaks will be equal to zero [165]. If you do not mean 
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center your data the first component does not really describe the largest direction of variation 
in the data, but rather it tends to describe the mean of the data, or at least some combination of 
the mean and the direction of largest variation.  
Normalization 
Normalization consists of dividing the spectra at each pixel by the total ion counts at that 
pixel. Normalization is typically done to reduce topographic or matrix effects.  
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Aim of the study 
1) To test new technique “high-pressure frozen” for preserving tissues for TOF-SIMS 
analysis  
2) To use imaging TOF-SIMS to localize different lipids in human adipose tissue and 
skeletal muscle.  
3) To test whether multivariate analysis of TOF-SIMS spectra can be used for studying lipid 
changes: 
a) In the skeletal muscle, associated with obesity 
b) In the aorta, associated with high glucose intake  
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Methods and materials 
Sample preparation  
Human adipose tissue and skeletal muscle (paper I and II)  
Healthy volunteers with a high body-mass index (age 14-16 yr, BMI>30, n=3) were used as 
subjects. A subcutaneous adipose tissue was obtained using the percutaneous needle biopsy 
technique with suction. A small piece of skeletal muscle was obtained after administration of 
local anaesthesia, by a Bergström needle (6 mm) from the middle part of lateral vastus muscle 
in the right leg. The biopsies were directly placed in ice-cold phosphate buffered saline (PBS; 
pH 7.4) until used for high-pressure freezing.  
Rat aortic wall (paper III)  
Aortas were taken from male Wistar rats with or without glucose drinking from birth to 6 
months of age, directly placed into ice-cold phosphate buffered saline (PBS; pH 7.4) until 
used for high-pressure freezing, same procedures as described above.  
High-pressure freezing and freeze-fracturing  
An equal procedure was utilized using high-pressure freezing and freeze-fracturing in 
experiments of paper I, II and III. High-pressure-freezing was preformed at 2000 bar and -
196◦C using the EMPACT high pressure freezer (Leica, Vienna) as described in details by 
others [160]. Briefly, the sample is placed into a specimen holder composed of a gold carrier 
and a copper ring sealed on the top. The carrier is inserted into a pressure chamber through 
which the pressurized liquid nitrogen is jetted and the sample is quickly frozen. This 
procedure immobilizes cell components immediately. Samples were quickly transferred onto 
a pre-cooled copper block in a liquid nitrogen bath. With help of a pair of forceps, the copper 
ring was removed from the gold carrier to lay open a fractured surface. The sample on the 
carrier was transferred to a vacuum chamber and freeze-dried over night at 10-3 mbar. The 
freeze-dried tissues were kept in a desiccator under vacuum until TOF-SIMS measurements. 
The copper-rings were placed in a box filled with absolute ethanol and kept in -20◦C until 
used.   
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Mouse skeletal muscle (paper IV) 
Mice were anaesthetized with isofluran, and gastrocnemius skeletal muscle was extirpated and 
frozen immediately.  
Cryo-sectioning 
In paper IV cryo-sectioning was performed at -20 ºC with a Leica cryostat.  
The frozen-tissue blocks were attached were taken from the -80 degree freezer and thawed in 
the cryostat machine for 45 min before the sample were sectioned. The sample was fastening 
with a sucrose solution on the tissue holder. Slices of 16 µm were cut, placed on an object 
slide and kept in the freezer at -20 ºC. Before measurement, the samples were freeze-dried in 
a vacuum chamber over night and directly analysed in vacuum by TOF-SIMS. 
TOF-SIMS analysis 
Measurements were performed using both an ION TOF TOF-SIMS IV and an ION TOF 
TOF-SIMS V instruments. Spectra of positive and negative ions were recorded using 25 keV 
Bi3+ primary ions and low-energy electron flooding for charge compensation as described 
previously [120]. To identify ion species present at respective surfaces the bunched mode was 
used. Spectra were recorded with the instrument optimized for maximum mass resolution 
(m/∆m = 3000–6000, beam diameter 5 µm, pulse width 10 ns, repetition rate 5 kHz) .The 
average primary ion current was 0.1 to 0.15 pA. Subsequently, high resolution secondary ion 
images (m/∆m 500, beam diameter  300 nm) were acquired in the burst alignment mode with 
a target current of 0.04 pA to 0.1 pA. Data were collected from several image fields on each 
section.  The primary ion doses were kept well below the so-called static limit of 1013 
ions/cm2. 
Pulse Mode 
Two different modes have been used in imaging lipids in this thesis.  
The bunched mode 
The bunched mode means that ion pulses that LMIG bombard the surface with are bunched 
and in a short pulse (10-30 ns pulse). This mode provides a high mass-resolution (∆/∆m 
  
3000-6000) and a mass spectrum with thin peaks, but low lateral resolution (around 5 µm).  
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The burst alignment mode 
The burst alignment mode means that the ion squirt is well-focused without the ability to 
compress the ion-pulses in time, thus primary ion bombardment occurs in a long pulse period. 
This mode provides high-lateral images (around 100 nm) however; the mass resolution is low 
(m/∆m < 500) and peaks are broader [115]. 
Charge compensation  
TOF analysis depends on the sample being at its ground potential, otherwise the primary ion 
beam can be deflected by the sample charging and the secondary ions energies will be 
different [140] and their yield is reduced [112]. By irradiation of the surface with low energy 
electrons this is avoided. To handle this problem TOF-SIMS instrument is provided by an 
electron flood gun [113]. This function is activated during TOF-SIMS measurements. 
 
Region of Interest analysis 
Region of interest, abbreviated ROI, is imaging software tool. This is used to select specific 
regions within the image for particular purposes. ROI was used in paper I and IV. For defined 
regions (any shape and size) whitin the analysed area, it is possible to sum the mass spectra 
with the help of ROI at the entire pixel points within each defined region.  
Morphology 
The fractured copper rings that kept in ice-cooled ethanol 99% were transferred to propylene 
oxide and embedded in epoxy resin. Semi thin sections (about 0.8 µm thick) were cut with a 
Leica Ultracut R ultramicrotome, equipped with an FC 4E cryounit, collected on super frost 
glass and air-dried at room temperature. Tissue sections were stained with toluidine blue/azan. 
For visualization of slow twisted skeletal muscle fibres sections were incubated with 
monoclonal anti-skeletal myosin (slow) (1:100 dilution Sigma-Aldrich, St Louis, Missouri). A 
controlled corrosion of the section surface was obtained by etching the section for at least 15 
min in sodium ethoxide diluted to 50 % with absolute ethanol and subsequently rehydrating in 
descending concentrations of ethanol. For histological analysis of lipids, 5 µm thick fresh 
frozen OCT imbedded skeletal muscle tissue sections were used and stained with oil-red. All 
histological stainings were analysed with microscopy automated software (KS400, Zeiss). To 
obtain information about tissue surface, the sample on the carrier that was used for TOF-
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SIMS analysis was coated with palladium using an Edwards Xenosput 200 sputter. Scanning 
electron microscopy was performed using a Zeiss 982 Gemini.  
Statistics 
Variance patterns within the TOF-SIMS peak intensities were analysed by principal 
component analysis (PCA), described in detail elsewhere (10), using PLS_Toolbox 4.0 
(Eigenvector Research, Wenatchee,WA) for MATLAB Version 7.1.0.246 R14 (The 
MathWorks Inc., Natick, MA). Spectral variations between samples are visualized in score 
plots, in which each dot represents an individual sample. The loadings plots show the 
contribution of each original variable (ion peak) to the new variables, principal components 
(PCs). All significant peaks with intensities above 50 count in the m/z region of 200-900 in 
the negative ion spectra and of 300-900 in the positive ion spectra were selected for analysis. 
Peak intensities were normalized to total ion intensities, and the data was auto-scaled before 
analysis. To further elucidate differences between two groups, the data were analyzed with 
Student’s unpaired t test. Values are presented as means ± SD. A p-value less than 0.05 were 
considered statistically significant. 
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Summery of Results 
Paper I  
The most significant lipids found in human adipose tissue are palmitic acid (C16:0) at m/z 
255, palmitoleic acid (16:1) at m/z 253, oleic (C18:1) at m/z 281 and stearic acid (18:0) at m/z 
283. The phosphocholine head group at m/z 184, cholesterol at m/z 385, diacylglycerols in the 
m/z of (550 - 640) and triacylglycerols in the m/z (830 - 880) were also identified. The 
distribution of lipids in human adipose tissue was heterogeneous, with cholesterol localized in 
intracellular organelles and in the lipid droplets and FA/TAG localized in the lipid droplets. 
Thus, TOF-SIMS equipped with Bi3+ LMIG provides us an extra possibility to detect and 
localize different lipids in human adipose tissue at their original localization.  
Paper II  
This paper shows heterogeneous distribution of lipids in the human skeletal muscle. The most 
significant lipids found in human skeletal muscle are palmitic acid (C16:0) at m/z 255, 
palmitoleic acid (16:1) at m/z 253, oleic (C18:1) at m/z 281 and stearic acid (18:0) at m/z 283. 
The phosphocholine headgroup at m/z 184 representing phosphatidylcholine and 
sphingomyelin, cholesterol at m/z 385, diacylglycerols in the m/z (550 - 640) and 
triacylglycerol in the m/z (830 - 880) were also identified. The PC was mostly localized to the 
edge of the fibre, representing the sarcoplasma or endomysium. Cholesterol was weak, and 
more scattered in the edge of the muscle fibre. The fatty acids were scattered all over the 
fibre, more intensed in some area which could be related to the Type-1 skeletal muscle fibres. 
High DAG signal and low TAG signal were detected within the muscle fibre. 
Paper III  
In this paper multivariate analysis of TOF-SIMS spectra was used as a semi-quantitative tool 
for measuring lipids in the aortic wall. Rats were divided into two groups, with or without 
glucose in their drinking water from birth to 6 months of age. The results showed a 
statistically significant reduction in cholesterol ion intensity the aortic wall. The present study 
also showed that ratio of palmitoleic over palmitic acid (C16:1/C16:0) was increased and the 
ratio of linolenic over oleic acid (C18:2/C18:1) was decreased. The same pattern was shown 
for the ratios of DAGs with different fatty acid residues.  
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Paper IV 
The results of Paper IV showed that there was an increased signal intensity of fatty acids and 
DAGs in skeletal muscle of the obese ob/ob mice. ROI showed that fatty acid signal 
intensities within the muscle cell were significantly increased in the ob/ob mice. These 
changes were revealed through, PCA analysis of TOF-SIMS spectra. TOF-SIMS images 
showed also increased fatty acids and DAGs in the skeletal muscle of the obese ob/ob mice 
when compared with the lean wild-type mice. Moreover, analysis of the ratio between 
different fatty acid peaks revealed changes in MUFA and PUFA that have been reported early 
in obesity. These changes in fatty acid composition were also reflected in the ratio between 
different DAGs and phosphatidylcholine that contain different fatty acid residues.  
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Results and Discussion 
Tissue preserving method 
The samples in papers I, II and III were preserved by high-pressure freezing, freeze-fracturing 
and freeze-drying. When samples are prepared by high-pressure freezing, all analytes in an 
intact cell are preserved at their original location [160]. TOF-SIMS is a surface-sensitive 
method, it is very important to avoid surface contamination which can hide native molecules 
in a tissue sample. In the freeze-fracturing process the sample is cracked into two parts 
generating two new fresh surfaces without contacting the preparation environment. One 
surface was used for TOF-SIMS imaging and another complementary surface was used for 
histological stainings. According to earlier studies, the fractured plane of a biological sample 
is irregular and extends along the inner hydrophobic area of the lipid bilayer in the plasma 
membrane or surfaces of organelles [166]. The irregular surface can lead to topographic 
effects that can present apparent enrichments or depletions of molecules, which have to be 
taken under consideration in the interpretation of images [167]. Although TOF-SIMS usually 
requires flat sample surfaces, rough surfaces can also be investigated [168]. However, care 
has to be taken when interpretating the data. Accordingly, both the human adipose tissue and 
skeletal muscle samples were freeze-fractured and were affected by topographic effects. 
Topographic effects will give significant effects on the yield of the secondary ions, e.g. band 
broadering and loss of signal intensities [134]. To compensate for topographic and/or matrix 
effects in rough samples, it is possible to divide the spectra at each pixel by the total ion 
counts at that pixel, so-called normalization. Another approach is to use principal component 
analysis where images are normalized against the first principal component [165]. However, 
normalization seems to result in loss of contrast and vividness in the image, so neither of these 
two normalization methods was applied for the images shown in this thesis.  
Cryo-fix and cryo-sectioning 
In paper IV, samples were plunge-frozen in liquid nitrogen and cryo-sectionized. The cryo-
sectioning resulted in a smoother surface, thereby avoiding topographic affects in the sample 
(see fig 8a and b). Thus, less interference from topographic effects makes the semi-
quantitative measurements of data more consistent. A drawback of cryo-sectioning is the 
possible ice-crystallization of water in the sample surface due to shift temperature. However, 
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a b 
ice-crystallization can be minimized if the tissue is cryofixed directly with a cryogen. We did 
not observe any influence of ice-cryztal formation, despite the fact that samples were 
untreated. To avoid water interfering in the mass spectra, a freeze-drying step in ultra-high 
vaacum before analysis is necessary [169]. This can cause ion motility and shrinkage of the 
sample. However, this step was used in both methods and for all of the samples. In addition, 
another disadvantage with the cryo-sectioning method is the possible ion redistribution when 
slicing the tissue [169].  
 
 
 
 
 
 
 
Figure 8 Total positively charged secondary ion TOF-SIMS images from cryofixated and 
cryosectionized mice skeletal muscle (a) and high-pressure-frozen and freeze-fractured human skeletal 
muscle (b). 
 
 
Na+ and K+ ions are good markers for a successful fixation of the tissue. In an intact cell the 
K+ ion concentrations are higher within the cell and Na+ ions are higher in the extracellular 
compartments. If the cell is damaged, the membrane does not offer any barrier to ion 
gradients and the cell looses K and gain Na for equilibrium within the cells (see figure 9) 
[170]. 
a b
 
Figure 9 Illustrative images from mice skeletal muscle where in (a), Na+ is visualized in extracellular 
compartments in red and K+ in intracellular compartments in green. b), shows Na+ in red, PC head 
group in green and merged signals in yellow  
a b a b
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TOF-SIMS imaging of fat and muscle tissue  
In papers I and II the TOF-SIMS technique was used to study lipid distribution in the human 
adipose tissue and skeletal muscle from obese youth. In paper I, high cholesterol signals were 
detected in the membrane of the adipocytes, a finding that is in agreement with previous 
results [56]. Other studies have shown that approximately 6% of the total cholesterol is 
located in the lipid droplets, in the form of cholesteryl esters [53]. Moreover, our data showed 
that clear-cut signals of DAG, fatty acids and low levels of TAG were located to the central 
part of the adipocyte. High CN signals derived from proteins and nucleic acids were found in 
structures related to loose connective tissue. The result of low TAG was unexpected, 
considering that lipids in the adipocyte contain 90-99 % of TAG. The reason for the low TAG 
signal is not clear. It might be that their high masses reduce their ability to reach high ion 
intensity. Another possible explanation is fragmentation of TAG. Indeed, in addition to TAG 
peak, we observed DAG peak in the TAG reference spectra. Fragmentation makes the lipid 
identification complex. However, fragmentation is also necessary to ensure the accuracy of 
lipid identities. The characteristic peak intensity ratio and “fingerprint patterns” are used to 
distinguish different compounds. The localization of fragments from one molecule may give 
us information of its possible relations to other fragments and their parent ions. For example, 
areas which exclusively express fatty acids or DAG without TAG indicates that fatty acids or 
DAG are naturally occurring molecules. Thirdly, low signal intensities of specific ions can 
also be caused by topographic features. Topographic effects could occur in the freeze-
fractured sample surface as irregularities in the sample surface may affect the sputtering 
process of secondary ions. However, matrix effects caused by the high contribution of the 
secondary ions of K+ and Na+ localized to some areas in the sample are probably to some 
extent contributing to the shift in ion signals. These ions can either reduce the levels of other 
ion signals, the so-called quenching effect, or contribute to enhanced emission of some 
molecules. In cultured adipocytes, about 20-50 % of DAG is newly synthesized, however, less 
than 1% of DAG is accumulated in the adipocyte in vivo [171,172]. It has been shown that 
TAG synthesis, and/or lipolysis, may influence the accumulation of DAG in the adipose tissue 
[173]. In line with this, high DAG signals were observed in the adipose tissue, which probably 
arises from fragmented TAG as shown by reference spectra. Moreover, some of the DAG 
signals observed in the adipose tissue are probably unique localizations in the sample that are 
not related to TAG. High signals of fatty acids were also depicted in the adipose tissue. As the 
amount of non esterified fatty acids is low in the adipose tissue, it is probable that some of the 
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fatty acids emanated from fragmented TAG, DAG or PC. We observed that the most abundant 
fatty acids in adipose tissue, skeletal muscle and aortic wall were palmitic acid (C16:0) at m/z 
255, and oleic acid (C18:1) at m/z 281. These are also the most frequent fatty acids in the 
circulation [174]. High levels of palmitic acid can lead to insulin resistance due to changes in 
the level of phosphorylation of the insulin receptor and insulin receptor substrate-1. Moreover, 
we identified linolenic acid (18:2) at m/z 279 a fatty acid that is used in the synthesis of 
prostaglandin. Low peaks at m/z 283 representing stearic acid (18:0) were identified from 
mass spectra of all tissues investigated in this thesis. Stearic acids are not so abundant in 
human tissues compared to palmitic acid (16:0) the incorporation into TAG and cholesterol is 
30-40% lower while its incorporation into PC is 40% [27]. Accordingly, in mass spectra from 
human adipose tissue there were almost no TAG peaks found in the region of m/z 886-890 
which are the peaks for TAG with stearic fatty acids incorporated in the fatty acid tails (see 
figure 11). The same pattern could be seen in the skeletal muscle, figure not shown. 
 
 
            Figure 10 shows a spectrum from human adipose tissue in the range of m/z (800-1000) 
 
Intake of an energy-rich diet will lead to obesity and lipid overloading in non-adipose tissues, 
so called ectopic tissues, in particular the insulin-sensitive skeletal muscle. In paper II TOF-
SIMS was applied to image lipids in the skeletal muscle. Since ion microscopy is not a 
morphological tool, complementary techniques are generally needed for identification of 
microstructures in the SIMS image. In this study we have used scanning electron microscopy 
to identify morphology in areas where TOF-SIMS images were studied. Low TAG signals 
were detected in the skeletal muscle, probable due to the fact that the amount of lipid is 
generally much lower in the skeletal muscle than in adipose tissue. Moreover, TAG is likely 
to be fragmented in the same way in the skeletal muscle as in adipose tissue. Storage of 
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intramyocellular TAG in the skeletal muscle is associated with insulin resistance [175]. 
However, the primary cause of insulin resistance is not TAG, rather other intermediates of 
TAG like DAG, fatty acyl-CoAs or ceramide. DAG is known to activate protein kinase C 
(PKC). Site of PKC phosphorylates of serine/threonine residue on insulin receptor substrates, 
which inhibits insulin signalling [34]. Interestingly, high DAG signals in the m/z range 550-
640 were detected in the skeletal muscle. The phosphocholine signals, on the other hand, were 
much more intense in the skeletal muscle than in the adipose tissue. This is probably due to 
the abundant sarcolemma and endomysium, which covers the skeletal muscle fibre. In 
addition, the skeletal muscle had low ion intensities of cholesterol. Accordingly, the 
cholesterol content in the skeletal muscle is only half that of the TAG content [154,155]. 
Endogenous cholesterol synthesis is low in the skeletal muscle and most cholesterol is 
transported from lipoproteins in the circulation [176]. 
We found that in the skeletal muscle, a highly complementary localization of fatty acids, 
DAGs and TAGs can be seen in the intracellular part of muscle cells, whereas PC and 
cholesterol are mostly located in the edge of the cells, probably in the plasma membrane e.g. 
sarcolemma. Low levels of cholesterol were scattered intracellularly in the fibre, possibly in 
the intracellular organelles such as the sarcoplasmic reticulum and the mitochondria. Earlier 
studies have shown that cholesterol is abundant in the lipid-laden caveolae of the sarcolemma 
[177]. Cholesterol is also found in the T-tubule and to a lesser amount in the sarcoplasmatic 
reticulum and mitochondria membrane [178]. The sarcolemma fluidity depends on the 
cholesterol content. Phosphatidylcholine is a major phospholipid found in the membrane of 
the sarcolemma, T-tubule and the sarcoplasmatic reticulum of the skeletal muscle cell [179]. 
We observed that the cholesterol-to-phospholipid ratio detected in the adipose tissue were 16 
times higher than in the skeletal muscle.  
Semi-quantitative comparation of TOF-SIMS spectra 
In papers III and IV, static TOF-SIMS was used as a tool for semi-quantitative measurements 
of lipid alteration in tissues. To achieve this, we used principal component analysis (PCA) to 
reduce the data-set and to extract the most important information embedded in the data [115]. 
The 3-dimension score plot of the negative spectra in paper III showed that glucose-drinking 
rats could be distinguished from control rats on the PC2 and PC3 axes. The corresponding 3-
dimension loading plot showed that linoleic acid (C18:2) was the main contributor to 
differences between the two groups. Further, the 3-dimension score plot of the positive 
spectra showed that the glucose-drinking rats could be distinguished from control rats 
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presumably on the PC2 and PC3 axes.  The corresponding 3-d loading plot showed that the 
main contributor to this deployment was DAG and cholesterol. In addition, the ratios of 
different fatty acid peaks were calculated. Hereby, we found that the ratio of palmitoleic acid 
(C16:1) over palmitic acid (C16:0) was increased; while the ratio of linolenic acid (C18:2) 
over oleic acid (C18:1) was decreased. The same approached was used for DAG signals in 
positive spectra. We found the ratio of DAG with MUFA residues over DAG with SFA 
residues was upregulated. While, the ratio of DAG with PUFA residues over DAG with 
MUFA residues was significantly reduced in the glucose-drinking rats when compared with 
the control rats. This is in line with another study in sucrose-fed rats, where the proportion of 
MUFA were increased and PUFA was decreased [180]. 
 
 
In paper IV the same principal was used to explore lipid differences in skeletal muscles 
between the obese and lean mice. We observed increased signals in fatty acid and DAGs in 
the skeletal muscle from obese mice. Accordingly, increased fatty acid deposits in tissues of 
the ob/ob mice have been reported earlier [181-184]. The 3-dimensional score-plot from 
negative spectra of the skeletal muscle showed that the ob/ob mice could be distinguished 
from the lean wild-type mice mainly on the PC2 and PC3 axes. The corresponding loading-
plot identified palmitoleic, oleic and linoleic acids as the main contributors to the cluster of 
the ob/ob mice. Furthermore, the 3-dimensional score-plot of the positive spectra from the 
skeletal muscle distinguished ob/ob mice from the wild-type mice, mainly on the PC2 and 
PC3 axis. The corresponding loading-plot showed that the main contributors were DAGs and 
cholesterol. The ratio between different fatty acids showed that the proportion of palmitoleic 
acids and oleic acids was upregulated while the proportion of linoleic acid was decreased in 
the ob/ob mice as compared to the lean mice. This is in line with changes in MUFAs and 
PUFAs that have been reported earlier in obesity [181,183]. These changes in fatty acid 
composition were also reflected in the ratio between different DAGs and phosphatidylcholine 
that contain different fatty acid residues as shown in our study. Moreover, it has been shown 
that increased MUFA concentrations in muscle phospholipids are positively correlated with 
fasting insulin concentrations and insulin resistance [185,186]. One of the reasons for the 
accumulation of MUFA is the activation of the enzyme stearoyl-CoA desaturase (SCD-1) 
associated with obesity. SCD-1 is rate limiting enzyme catalysing the synthesis of MUFA, 
mainly oleic and palmitoleic acids, which are major component in tissue lipids [187].   
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Further, we observed that arachidonic acid (C20:4) over dihomo-gamma-linolenic acids 
(DGLA, C20:3) were upregulated, while DGLA over linoleic acids decreased in the obese 
ob/ob mice. The increased C20:4/C20:3 ratios and its relation to obesity and insulin resistance 
are controversial since both increment and decrement have been reported in obese subjects 
[17,188]. 
Moreover, region-of-interest analysis showed that fatty acid signal intensities within the 
muscle cell were statistically significantly increased in ob/ob mice compared with the lean 
wild-type mice. The increased DAG may contribute to insulin resistance through the 
activation of protein kinase C family [12]. Moreover, insulin resistance is characterized by a 
specific fatty acid pattern in the serum lipid esters, as well as in lipid storage and in cell 
membranes of the skeletal muscle. TOF-SIMS overlay images showed that palmitic and oleic 
acids were located within the same muscle fibre, whereas stearic acid seemed to be located in 
other fibres (see figure 11). It is known that the lipid content is higher in oxidative type-1 
fibres than in type-2 skeletal muscle fibres. Oxidation of stearic acid has been shown to be 
significantly less than that of oleic acid in both the fed and fasted states [189]. By this 
background it is possible that palmitoleic and oleic are located to the oxidative type-1 fibres 
whereas stearic acid is located to type-2 fibres. 
 
Figure 11 shows TOF-SIMS image of a cryofixed and cryosectionized skeletal muscle sample from an 
ob/ob mouse. The different fatty acid distribution is shown whitin the skeletal muscle fibre in different 
colour according to their distribution. Palmitic acid at m/z 255 is shown in red colour, oleic acid at m/z 
281 shown in green and stearic acid at m/z 283 shown in blue colour 
 
 
However, some technical details about TOF-SIMS and its influence on quantification are 
needed to be taken in consideration when quantification approaches is performed. First, the 
absolute ion yield in a sample depends on the surrounding molecules, their chemical binding 
and the type of environment to which they are associated. Cationization of molecular ions 
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with Na+ and K+ may for example influence the ion yield of a specific ion. Na+ is known for 
cationisation with ceramides, and the presence of water in the sample surface will increase ion 
intensity of phosphocholine [190]. This so-called matrix effect is a known phenomenon in 
TOF-SIMS methodology [191]. Thus, when quantifying with TOF-SIMS data, the matrix 
effect has to be taken into consideration. TOF-SIMS has been shown to be useful in 
quantifying cyclosporine A in blood samples [192] and cocaine has been successfully 
measured by TOF-SIMS in urine [151]. In these studies, known concentration of internal 
standards was added to the sample, and by calibration curves, it was possible to determine the 
concentration of the analytes of interest in the sample. However, this approach is very difficult 
to apply on tissue as it is difficult to add internal standard to the tissue as it would hide native 
molecules. Moreover, the concentration of analyte molecules at the very surface must be 
known and typically we only know the bulk concentration of a reference sample. Instead, 
using appropriate control group offers the possibility for comparing analytes from the same 
type of tissue in different groups. When quantitatively comparing samples from similar areas 
in the same type of tissue (matrix), the matrix effect should be similar from one sample to the 
other, and the secondary ion yields are likely to be similar. Variations in other parameters, 
such as the surface inclination, acquisition time, primary ion source and current, the angle of 
the beam and charge state of the matrix, should also be the same [135,193]. Thus, it is also 
possible to calculate the ratio of different peaks within the same sample and to compare the 
ratios between different groups. With this approach we identified differences in the fatty acid 
composition as a result of obesity and high glucose intake. 
 
High-carbohydrate diet and lipid accumulation in the aortic wall 
It has been shown that a high-carbohydrate diet contributes to obesity with raised TAG and 
reduced HDL content in blood plasma [194]. Accordingly, we found that rats with a high-
glucose intake had both an increased plasma TAG and a reduced HDL-cholesterol level. 
Lowering of the HDL-cholesterol level plays an important role in endothelial activation and 
accumulation of cholesteryl esters in the aortic wall [195,196]. However, our study showed 
decreased cholesterol signals in the aortic wall. Despite the reduced HDL-cholesterol in the 
glucose-drinking rats, the level of LDL-cholesterol and total cholesterol remained unchanged. 
It has shown that high-carbohydrate diet reduce blood levels of both HDL- and LDL-
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cholesterol plasma levels [197]. It is possible that both reduced HDL-and raised LDL-
cholesterol plasma levels are required for cholesterol accumulation in the aortic wall.  
 
 
Figure 12 shows the TOF-SIMS image of the rat aotic wall where cholesterol is shown in red colour, 
mainly located to the lamella regions and the PC is shown in green colour which surround the 
cholesterol signals.  
 
 
It has shown that rats fed a high-fat diet had reduced body weights, and volume and number 
of adipocytes compared to rats receiving a high-carbohydrate diet.  Even though rats fed a 
high carbohydrate diet gained more fat the lipolytic activity in the aortic wall was not reduced, 
while this occurred in rats fed with high-fat diet. In addition rats fed with high-fat diets had 
also a higher lipid disposition in the aortic wall than rats fed with high-carbohydrate diet 
[198]. Moreover, rats receiving diet high in saturated fat for 15 months had no vascular 
changes in coronary arteries or aorta despite significant differences in plasma triglyceride and 
cholesterol levels [199]. Thus, high-carbohydrate diet does not necessarily lead to lipid 
accumulation in the aortic wall. Accordingly, we showed that high glucose intake in rat did 
not lead to more intensed lipid signals in the aortic wall. In contrast, glucose-drinking led to 
decreased cholesterol ions signals in the aortic wall.  
The association between increased plasma triglyceride-rich lipoproteins and a high lipid 
accumulation within the aortic wall is complex. Metabolic disorder resulting in severe 
increase in triglyceride-rich lipoproteins, such as lipoprotein lipase deficiency, is not 
associated with an increased risk of atherosclerosis. In these disorders, lipoproteins are of 
such size that they cannot enter the aortic wall and thus do not directly promote atherogenesis 
[200,201]. Lipoproteins primarily carry two type’s lipids: cholesterol and TAG. However, 
these two lipids have different fats. TAG is mainly transported into adipose tissue and skeletal 
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muscle where the fatty acids are stored or oxidized for energy production. Cholesterol is 
continuously transported between the liver, intestines and other extrahepatic tissues.  
Cholesterol serves as a structural component of the cellular membrane and as a precursor to 
the synthesis of steroid hormones and bile acids [86].  
The liver X receptors (LXRs) are involved in lipid metabolism and reverse cholesterol 
transport, glucose has been shown to be an LXR agonist and upregulated in the expression of 
the LXR gene [90]. LXRs are expressed in endothelial cells [88] and in human coronary 
artery vascular smooth muscle cells [89]. LXR stimulates cholesterol efflux to lipid-poor 
apolipoproteins [202]. It is possible that high-glucose intake can activate LXRs in the aortic 
wall and this pathway may explain the decreased cholesterol in the rat aorta.  
Moreover, we observed that rats receiving high glucose intake had a major reduction of 
pellets consumption, probably due to the high energy intake of glucose reducing their hunger, 
which has been seen in other studies [203]. This means that their protein intake was lowered 
during six months of life. Interestingly, a low-protein diet during neonatal and postnatal life 
has been shown to reduce arterial wall thickness and elastic tissue [204]. The reduction in 
protein intake during neonatal and postnatal life probably contributed to the reduction of 
cholesterol in the aortic wall. It has been shown that elastic tissue is important for the 
accumulation of lipids in the aortic wall, as elastine forms stable complex together with 
cholesterol [82]. TOF-SIMS images of rat aorta showed that cholesterol and oxysterols are 
located to the elastic lamellae in the aortic wall [205] (see figure 12). Furthermore, correlation 
between collagen synthesis and cholesterol has been shown [206].  Moreover, high-pressure 
freezing has been shown to retain relationships between cells, collagen and elasin in the aortic 
media [207]. Thereby, this would be adequate method of preserve samples for semi-
quantitative measurement of lipids in the aortic. Thus, it is possible that the decreased 
cholesterol signals in the aortic wall are caused by protein deficiency during neo- and 
postnatal life due to high glucose consumption. Reduced HDL-cholesterol levels in the blood 
lead to augmented cholesterol concentration primarily in the adipose tissue, which is our 
body’s largest cholesterol storage compartment [51]. Moreover, it has been shown that 
cholesterol depletion in the endothelial cell increases the stiffness of the membrane by altering 
the properties of the submembrane F-actin and/or its attachment to the membrane [208]. 
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Conclusions 
This thesis showed the possibility of using TOF-SIMS in tissue research. Peaks from fatty 
acid, DAG, TAG cholesterol and phosphatidylcholin were identified in the TOF-SIMS 
spectrum, from the skeletal muscle, adipose tissue and aortic wall, tissues which are 
connected to insulin resistance and metabolic syndrome. This thesis is also revealing a semi-
quantitative way of using TOF-SIMS for comparation of lipids in the aortic wall and in the 
samples of mouse skeletal muscle. By principal component analysis we were able to reveal 
changes of lipids in the samples between experimental and control groups. This revealed 
interesting data with the use of unfixed samples. TOF-SIMS is an interesting technique of 
mapping lipids in biological tissues and future experiment with this technique should improve 
the knowledge of lipids interaction in metabolic diseases and cellular processes. 
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